Variants, vaccine efficacy, and the tests labs need

Speaking in a CAP TODAY webinar on variants and their detection, Dr. Glen Hansen said diagnostic manufacturers have shown that variant assays can be brought to market for clinical laboratories. “And we need to support them so that when a clinically valid mutation comes around that we need to look for, we have the chance to do it,” he said in the April 28 webinar made possible by a special educational grant from Seegene Technologies.